USD/TRY Price Analysis: Monthly support tests further downside around $13.50

USD/TRY licks its wounds near early December lows after the biggest daily slump on record.
Erdogan unveiled series of measures to stop further dollarization, around $1.0 billion was sold after announcement.
Steady RSI suggests further consolidation of losses, 21-DMA guards immediate upside.
50-DMA acts as additional downside filter, bulls need clear break of $14.65 for confirmation.

USD/TRY pares the heaviest daily fall on record while taking rounds to $13.50, up 0.40% intraday, during early Tuesday.

The Turkish lira (TRY) pair’s downpour could be linked to a clear break of an ascending support line from November, in addition to the fundamental moves by Turkish President Recep Tayyip Erdogan.

“Speaking after a Cabinet meeting, Erdogan said the measures would ensure citizens would not have to convert their lira into foreign currency over the lira crash, including a deposit guarantee promise,” per Reuters. The news also quotes the head of the Turkish Banks Association while saying, “Around $1 billion was sold in markets after Erdogan unveiled the measures.”

Even so, one-month-old horizontal support around $13.20-15 restricts the quote’s further downside.

Although the MACD signals do favor bears, a clear downside break of $13.15 becomes necessary for the USD/TRY sellers to keep reins.

In doing so, the 50-DMA level of $11.43 and the $10.00 psychological magnet should become their favorites.

Alternatively, steady RSI and failures to conquer the immediate support can favor USD/TRY bulls if the quote rises past the 20-DMA hurdle surrounding $13.75.

Following that, the $14.00 round figure and previous support line near $14.60 will test the pair buyers before resuming the run-up to aim for the $20.00 round figure. During the rise, the $15.70 and the latest all-time high of $18.36 will be important to watch.

USD/TRY: Daily chart

Trend: Further recovery expected

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.